Crinetics Pharmaceuticals, Inc. (CRNX)
$84.97+$0.12 (+0.14%) Today
Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 3 | 9,900 | $366K |
| Grant or award | 15 | 110,056 | |
| Option exercise | 8 | 39,856 | |
| Bona-fide gift | 14 | 1,937,600 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
37 Form 4 filings on record, the earliest from Oct 7, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dana Pizzuti - Officer | Option exercise | Common Stock | 30,000 | $16.89 | $507K | |
| Dana Pizzuti - Officer | Open-market sale | Common Stock | 30,000 | $30.43 | $913K | |
| Dana Pizzuti - Officer | Option exercise | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| Dana Pizzuti - Officer | Open-market sale | Common Stock | 6,492 | $29.18 | $189K | |
 Wendall Wierenga | Grant or award | Common Stock | 6,900 | $0.00 | - | |
| Wendall Wierenga | Grant or award | Stock Option (right to buy) | 10,350 | $0.00 | - | |
| Stephen F. Betz - Officer | Option exercise | Common Stock | 2,331 | $1.91 | $4K | |
| Stephen F. Betz - Officer | Option exercise | Stock Option (Right to Buy) | 2,331 | $0.00 | - | |
| Richard Scott Struthers - Officer | Open-market sale | Common Stock | 10,000 | $57.57 | $576K | |
| Jeff E. Knight - Officer | Open-market sale | Common Stock | 501 | $56.52 | $28K | |
| Dana Pizzuti - Officer | Option exercise | Common Stock | 14,375 | $16.89 | $243K | |
| Dana Pizzuti - Officer | Open-market sale | Common Stock | 14,375 | $54.63 | $785K | |
| Dana Pizzuti - Officer | Option exercise | Stock option (Right to Buy) | 14,375 | $0.00 | - |
This is as far as the anonymous view goes. Create a free account for all 37 CRNX filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
Crinetics Pharmaceuticals, Inc. (CRNX) had 12 insider filings in the last 90 days, with the most recent on 2026-08-24. The full record for CRNX runs to 37 Form 4 filings, the earliest from 2024-10-07. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of CRNX were filed in the last 90 days.
3 insider sales of CRNX were filed in the last 90 days, totaling $366K.
This page tracks CRNX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add CRNX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
